Aleksandra Zielinska

Dr. Aleksandra Zielinska

orcid

Research Focus & Metrics

Academic Career Length

18Years (2009-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2012 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
HPHanna Pruchnik
Hanna Pruchnik
TLTadeusz Lis
Tadeusz Lis
MLMałgorzata Latocha
Małgorzata Latocha
AZAleksandra Zielinska
Aleksandra Zielinska
SUStanisław Ułaszewski
Stanisław Ułaszewski
FPFlorian P. Pruchnik
Florian P. Pruchnik


1 March 2016 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
HPHanna Pruchnik
Hanna Pruchnik
TLTadeusz Lis
Tadeusz Lis
MLMałgorzata Latocha
Małgorzata Latocha
AZAleksandra Zielinska
Aleksandra Zielinska
FPFlorian P. Pruchnik
Florian P. Pruchnik

1 December 2012 in Advances in Medical Sciences
Verified
Journal Article
Closed access
MFMarcin Fraczek
Marcin Fraczek
BRB Rostkowska-Nadolska
B Rostkowska-Nadolska
DKD Kusmierz
D Kusmierz
AZAleksandra Zielinska
Aleksandra Zielinska
JRJ Rok
J Rok
MLMałgorzata Latocha
Małgorzata Latocha

13 April 2020 in Disease Markers
Verified
Journal Article
Open access
PDF file
RSRenata Suchanek-Raif
Renata Suchanek-Raif
PRPaweł Raif
Paweł Raif
MKMalgorzata Kowalczyk
Malgorzata Kowalczyk
MPMonika Paul-Samojedny
Monika Paul-Samojedny
AZAleksandra Zielinska
Aleksandra Zielinska
JKJan Kowalski
Jan Kowalski
Aim. The BDNF dysfunction in the schizophrenia has been soundly documented. The TrkB gene is a high-affinity receptor of the BDNF that is changed in schizophrenia and mood disorders. The study had two aims: first, to identify whether the five nucleotide polymorphisms (SNPs) in TrkB gene are associated with a diagnosis of schizophrenia; and the latter, if any association exists between the TrkB SNPs and psychopathology, suicide attempts, and family history of schizophrenia in a Caucasian population. Methods. Case-control study (401 patients and 657 healthy controls) was used to examine a predisposition for schizophrenia. The tests for psychopathology, suicide attempts, and family history of schizophrenia were conducted only in patient group. The severity of the schizophrenia was measured using the five-factor model of the PANSS. In addition, the haplotype analysis for both the separate for SNPs of TrkB gene and in combination with the rs6265 SNP BDNF gene was conducted. Results. Our case-control study revealed that the genetic variants of rs10868235 (T/T polymorphic genotype) and rs1387923 (G/G polymorphic genotype) of the TrkB gene were associated with a higher risk of developing schizophrenia in men. However, the A/A wild genotype of rs1387923 was connected with a lower risk for both the development of and the family manifestation of schizophrenia in men. The G polymorphic allele of rs1565445 was associated with an increased risk of suicide in schizophrenia. The tested SNPs of the TrkB gene did not modulate the psychopathology of schizophrenia. The haplotype that was built with five SNPs in the TrkB gene was protective for men, but after joining the rs6265 SNP of the BDNF gene, a haplotype that was protective for women was created.

15 September 2015 in Advances in Clinical and Experimental Medicine
Verified
Journal Article
Open access
JPJustyna Płonka-Czerw
Justyna Płonka-Czerw
MLMałgorzata Latocha
Małgorzata Latocha
DKDariusz Kuśmierz
Dariusz Kuśmierz
AZAleksandra Zielinska
Aleksandra Zielinska
Breast cancer is the most common malignant tumour in women in the whole world. Despite significant developments in the early diagnosis of breast cancer, there is no effective method which would assure total recovery of the patient. Currently available clinical data and laboratory tests indicate a possibility to introduce photodynamic therapy (PDT) to the supplementary treatment of breast cancer. The aim of this study was to assess the influence of PDT with Photolon as a photosensibilizator on the expression of apoptosis associated genes (BCL-2, BAX, TP53) in human breast cancer cell lines, preceded by assessment of survivorship and proliferative activity in the tested cells after PDT. In the present study human breast cancer cell lines MCF-7 and T-47D were used. Photolon (chlorin e6 complex: PVP 1:1) was used as a photosensitizer. Assessments of survivorship and proliferative activity of cells under the influence of PDT (WST-1 test) were conducted along with the expression of selected genes involved in the process of apoptosis: BCL-2, BAX, TP53 (RT-QPCR). PDT limited both survivorship and proliferative activity of breast cancer cells in the two tested lines. In case of T-47D cell line was found increase of BAX and BCL-2 genes expression after PDT and sustained activity of TP53 gene. Conversely, in MCF-7 cell line a decrease in expression was found for both BAX and TP53 genes, but also an increase of BCL-2 gene expression. A progressing decrease (24, 48 and 72 h after PDT) in the count of culture cells, which suggests the occurrence of apoptosis initiated by a photodynamic reaction with simultaneous increase of BCL-2/BAX index, indicates activation of a different endogenous apoptosis pathway than the one examined, namely pointing to suicidal death of cells after PDT.